120 related articles for article (PubMed ID: 12678821)
1. Functionalized S-thio-di- and S-oligosaccharide precursors as templates for novel SLex/a mimetic antimetastatic agents.
Dey PM; Witczak ZJ
Mini Rev Med Chem; 2003 Jun; 3(4):271-80. PubMed ID: 12678821
[TBL] [Abstract][Full Text] [Related]
2. Affinity and kinetics of sialyl Lewis-X and core-2 based oligosaccharides binding to L- and P-selectin.
Beauharnois ME; Lindquist KC; Marathe D; Vanderslice P; Xia J; Matta KL; Neelamegham S
Biochemistry; 2005 Jul; 44(27):9507-19. PubMed ID: 15996105
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin.
Maaheimo H; Renkonen R; Turunen JP; Penttilä L; Renkonen O
Eur J Biochem; 1995 Dec; 234(2):616-25. PubMed ID: 8536711
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium.
Seppo A; Turunen JP; Penttilä L; Keane A; Renkonen O; Renkonen R
Glycobiology; 1996 Jan; 6(1):65-71. PubMed ID: 8991511
[TBL] [Abstract][Full Text] [Related]
5. In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.
Renkonen R; Mattila P; Majuri ML; Räbinä J; Toppila S; Renkonen J; Hirvas L; Niittymäki J; Turunen JP; Renkonen O; Paavonen T
Glycoconj J; 1997 Aug; 14(5):593-600. PubMed ID: 9298692
[TBL] [Abstract][Full Text] [Related]
6. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
Fuster MM; Brown JR; Wang L; Esko JD
Cancer Res; 2003 Jun; 63(11):2775-81. PubMed ID: 12782582
[TBL] [Abstract][Full Text] [Related]
7. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination.
Brown JR; Fuster MM; Li R; Varki N; Glass CA; Esko JD
Clin Cancer Res; 2006 May; 12(9):2894-901. PubMed ID: 16675586
[TBL] [Abstract][Full Text] [Related]
8. Macrosphelide B suppressed metastasis through inhibition of adhesion of sLe(x)/E-selectin molecules.
Fukami A; Iijima K; Hayashi M; Komiyama K; Omura S
Biochem Biophys Res Commun; 2002 Mar; 291(4):1065-70. PubMed ID: 11866473
[TBL] [Abstract][Full Text] [Related]
9. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion.
Turunen JP; Majuri ML; Seppo A; Tiisala S; Paavonen T; Miyasaka M; Lemström K; Penttilä L; Renkonen O; Renkonen R
J Exp Med; 1995 Oct; 182(4):1133-41. PubMed ID: 7561686
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode.
Renkonen O; Toppila S; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Turunen JP; Renkonen R
Glycobiology; 1997 Jun; 7(4):453-61. PubMed ID: 9184825
[TBL] [Abstract][Full Text] [Related]
11. Sialyl Lewis(x) (sLe(x)) and an sLe(x) mimetic, CGP69669A, disrupt E-selectin-dependent leukocyte rolling in vivo.
Norman KE; Anderson GP; Kolb HC; Ley K; Ernst B
Blood; 1998 Jan; 91(2):475-83. PubMed ID: 9427700
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the E-selectin ligand on NK cells.
Pinola M; Renkonen R; Majuri ML; Tiisala S; Saksela E
J Immunol; 1994 Apr; 152(7):3586-94. PubMed ID: 7511652
[TBL] [Abstract][Full Text] [Related]
13. C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.
St Hill CA; Baharo-Hassan D; Farooqui M
PLoS One; 2011 Jan; 6(1):e16281. PubMed ID: 21283832
[TBL] [Abstract][Full Text] [Related]
14. Sialyl Lewis X mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity.
Rao BN; Anderson MB; Musser JH; Gilbert JH; Schaefer ME; Foxall C; Brandley BK
J Biol Chem; 1994 Aug; 269(31):19663-6. PubMed ID: 7519598
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines.
Monzavi-Karbassi B; Stanley JS; Hennings L; Jousheghany F; Artaud C; Shaaf S; Kieber-Emmons T
Int J Cancer; 2007 Mar; 120(6):1179-91. PubMed ID: 17154173
[TBL] [Abstract][Full Text] [Related]
16. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium.
Fujii Y; Yoshida M; Chien LJ; Kihara K; Kageyama Y; Yasukochi Y; Oshima H
Urol Int; 2000; 64(3):129-33. PubMed ID: 10859542
[TBL] [Abstract][Full Text] [Related]
17. E-selectin binding by pancreatic tumor cells is inhibited by cancer sera.
Sawada T; Ho JJ; Chung YS; Sowa M; Kim YS
Int J Cancer; 1994 Jun; 57(6):901-7. PubMed ID: 7515860
[TBL] [Abstract][Full Text] [Related]
18. Differences between human eosinophils and neutrophils in the function and expression of sialic acid-containing counterligands for E-selectin.
Bochner BS; Sterbinsky SA; Bickel CA; Werfel S; Wein M; Newman W
J Immunol; 1994 Jan; 152(2):774-82. PubMed ID: 7506734
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells.
Martín-Satué M; Marrugat R; Cancelas JA; Blanco J
Cancer Res; 1998 Apr; 58(7):1544-50. PubMed ID: 9537262
[TBL] [Abstract][Full Text] [Related]
20. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
